
--- Page 1 ---
i(b- 0 - 3 lnfilt^aHNg duct, N0s 85ouf3 Carcinoma PATIENT HISTORY: Site lole : Krest, Nos c 50.9 The patient is a year-old female with no clinical history given. Date of Tast menstrual period: Not given.. PRE OP DIAGNOSiS: Breast cancer. Post op Diagnosis: Same. PROCEDURE: Left totai mastectomy and sentine! node biopsy, Hepatitis C. UUID:E4DF4771-074D-4870-A03F-AF62724C5A86  TCGA-BH-A18L-01A-PR  Redacted FINAL DIAGNOSIS: Part 1: sentinel Lymph node, Left, #1 - Lymph nODe pOSItIvE fOR SEVErAL MICrOmetaStASES, AppROxImATeLy 0.1 Cm EACH, ViSIbLe On IMMUNOSTAIN SLIDES AND TWO LEVELS OF THE H&E STA!N SECTIONS. Part 2: SentInel Lymph NODe, Left, #2 - NEgative fOr metastAtic tumOR (see comment). PARt 3: NON-SENTiNEL LymPH NODE, LEfT --  Negative for metastatic tumor. Part 4: breast, Left, total mastectomy - A.  INFiLTRATiNG DUCTAL CARCINOMA, nOTTInGhAm SCORe 7i9 (TUBULeS 3, nUCLEAR PLeOmORPHISm 2, MitOsis 1) 6.0 X 5.0 X 6.0 Cm. B.  DUCTAL CARCINOMA IN SiTU, SOLID AND CRIBRIFORM TYPES REPRESENTiNG, APPROXIMATELY 5% OF TOTAL. TUMOR VOLUME. C. Skin wIth tumor in the LOWer dermIs. D. LINES OF RESECT!ON ARE FREE OF TUMOR. (See comment) COMMENT: The tumor is approximately 0.1 cm from the inferior surgical resectlon margin. The ductal nature of the tumor is. confirmed by a strongly positive E-cadherin immunostain.

--- Page 2 ---
MICROSCOPIC: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST A. Lateratity: 2 1. Right 2. Left B. Procedure: 3 1. Segmentectomy 3. Modified radical mastectomy 2. Simple mastectomy 4. Re-excision C. Location: 2 1. Central subareolar 4. LOQ 2. UOQ 5. LIQ 3. uiQ 6. Not specified D. Size of tumor (maximum dimension invasive component by gross or microscopic exam): 6.0 cm 1. Ductal, NOS 5. Cribriform 9. Metaplastic 2. Tubular 6. Papillary 10. Other 3. Mucinous 7. Lobular 4. Medullary 8. Carcinoid like F. If lobular carcinoma, specify type:  N/A 1. Classical 4. Signet ring 7. Pleomorphic 2. Solid 5. Trabecular 3. Alveoiar  6. Tubulobular G. Nottingham Score: G1. Nuclear grade: 3 G2. Tubule formation: 3 G3. Mitotic activity score: 1 G4. Total Nottingham score: Z G5. Nottingham grade (1, 2, 3): 2 H. Angiolymphatic invasion: 1 1. No 2. Yes I. Dermal lymphatic invasion: 2 1.Yes 2. No 3. Not applicable J. Calcification: 1 1. No 2. Yes -- benign zones 3. Yes -- malignant zones K. Type of in situ component: 1/2 1. Cribriform 4. Micropapillary 7. Lobular 2. Solid 5. Apocrine 3. Papillary 6. Comedo L. Percentage of tumor occupied by in situ component:  5% M. Surgical margins involved by invasive component: 1 1. No 2. Yes - focal 3. Yes -- diffuse N. Surgical margins involved by in situ component: 1 1. No 2. Yes - focal  3. Yes - diffuse O. Paget's disease of nipple: 2 1.Yes 2. No P. Number of positive lymph nodes: 1 Q. Total number of lymph nodes examined:3 R. Sentinel node metastasis: 1 1. Yes 2. No S. Only micrometastases to lymph nodes (none larger than 0.2 cm): 1 1.Yes 2. No T. Metastasis/es to a lymph node 2 cm. or more in greatest dimension: 2 1. Yes 2. No U. Lymph node metastasis/es with extracapsular extension:2 1. Yes 2. No V. Metastases to ipsilateral internal mammary lymph node (if applicable): N/A 1. Yes 2. No W. Skin involved (uiceration): N/A 1. Yes 2. No X. Non-neoplastic breast tissue: 6 1. ADH 4. Fibroadenoma 7. LCIS 2. ALH 5. Papilloma 8. Other 3. Radical scar 6. FCD Y. Multicentricity/multifocality of invasive foci: 2 1. Yes 2. No Y1: Sizes of invaxive foci: # cm/ # cm /# cm Y2: Aggregate diameter of Y1 tumors: # cm Z. TNM stage: T3N _mX